Restaurant Brands International Inc. Common Shares vs Repligen Corporation Common Stock — how do they compare? Restaurant Brands International Inc. Common Shares trades at $73.03 (market cap $24.77B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Restaurant Brands International Inc. Common Shares is far larger — about 2.2× Repligen Corporation Common Stock's market cap, and Restaurant Brands International Inc. Common Shares pays a 3.65% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Restaurant Brands International Inc. Common Shares for 6 Days and Repligen Corporation Common Stock for 0 Days on average.
| QSR | RGEN | |
|---|---|---|
Market Cap | $24.77B | $11.14B |
Volume | 3,180,422 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $81.67 | $194.57 |
52-Week Low | $65.69 | $102.87 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $39.38B | $11.02B |
Dividend Yield | 3.65% | — |
Signals from Pluang's Aura AI — not financial advice
QSR trades at $71.27, up 0.21% on the day, with a bearish technical signal driven by moving averages and oscillators. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.08. Revenue reached $9.43B in 2025, with net income of $776M, and is projected to grow to $9.7B in 2026. Analyst consensus is bullish with a price target of $84.80, supported by Burger King's turnaround momentum noted in recent news.
The outlook for QSR is positive due to strong earnings performance and analyst optimism, but near-term technical weakness and competitive pressures pose risks. Investment opportunity lies in execution of the Burger King revitalization and franchise strategy, while risks include market volatility and execution gaps in value offerings against rivals like McDonald's.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Restaurant Brands International owns and franchises quick-service restaurant brands, including Burger King, Tim Hortons, Popeyes, and Firehouse Subs.
Read more on QSR →Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →